Ashley Koff, RD 00:18:18 So I think the dosing needs to be more personalized
Observational links between GLP-1 exposure, lower hs-CRP, and fewer cerebrovascular/neurodegenerative events fit this biology, although only dedicated AD trials can confirm true disease modification
While anecdotal reports suggest GLP-1 drugs may reduce alcohol consumption, a Novo Nordisk spokesperson said a phase 2 trial will be studying semaglutide the active ingredient in Wegovy and Ozempic and related compounds for their effects on alcohol-related liver disease, with drinking habits monitored as a secondary outcome
2001 reported on the effects of astaxanthin cream on the size of 11 healthy women (ages 2140) applying 0.014 mg per day AstaReal astaxanthin topical application for three weeks
Off-label exploration by non-HIV patients requires robust medical evaluation and discussion of limited evidence outside the approved indication
What really helps with adherence is when the supplement has a pleasant taste and a practical presentation